Top managers were finding new places to put money to work and adding to existing high-conviction ideas in the first quarter.
FDA Approves TREXIMET (sumatriptan and naproxen sodium) for Use in Pediatric Patients
Mitralign To Update On Mitral and Tricuspid Repair Systems at EuroPCR 2015
Ligand Partner Viking Therapeutics Announces Closing of Initial Public Offering
Cadillac ATS-V and the strange joys of engine noise
CYREN Report: Q1 2015 Sees 51 Percent Increase in Phishing Sites
US Army Awards Harris Corporation $3.9 Billion Rifleman Radio IDIQ Contract
All investments involve risk, including possible loss of principal. The value of investments can go down as well as up, and investors may not get back the full amount invested. The information provided in this posting is not a complete analysis of every material fact regarding any country, region, or market. Comments, opinions and analyses contained herein are those of the author and are for informational purposes only. Because market and economic conditions are subject to change, the comments, opinions and analyses are rendered as of the date of this posting and may change without notice. Certain statements contained herein are intended to provide insight on macro-economic issues and this commentary is not intended as individual investment advice or a recommendation or solicitation to buy, sell or hold any security or to adopt any investment strategy. Reliance upon information in this posting is at the sole discretion of the viewer. Please consult your own professional adviser before ...
These top managers continue to focus on higher-quality dividend-paying stocks in a market that has become more volatile of late.
Top managers continue to find opportunities for new-money purchases (albeit fewer than in past periods), while taking full advantage of a rising stock market to book some gains.